Document Detail


HIF-Prolyl hydroxylases and cardiovascular diseases.
MedLine Citation:
PMID:  22424133     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Abstract Prolyl Hydroxylases belong to the family of iron- and 2-oxoglutamate-dependent dioxygenase enzyme. Several, distinct prolyl hydroxylases have been identifed. The Hypoxia-Inducible Factor (HIF) prolyl hydroxylase termed Prolyl Hydroxylase domain enzymes (PHDs) play an important role in oxygen regulation in the physiological network. There are three isoforms that have been identified: PHD1, PHD2 and PHD3. Deletion of PHD enzymes result in stabilization of HIFs and offers potential treatment options for many ischemic disorders such as peripheral arterial occlusive disease, myocardial infarction, and stroke. All three isoforms are oxygen sensors that regulate the stability of HIFs. The degradation of HIF-1α is regulated by hydroxylation of the 402/504 proline residue by PHDs. Under hypoxic conditions, lack of oxygen causes hydroxylation to cease HIF-1α stabilization and subsequesnt translocation to the nucleus where it heterodimerizes with the constitutively expressed β subunit. Binding of the HIF-heterodimer to specific DNA sequences, named hypoxia-responsive elements (HREs), triggers the transactivation of target genes. PHD regulation of HIF-1α-mediated cardio-protection has resulted in considerable interest in these molecules as potential therapeutic targets in cardiovascular and ischemic diseases. In recent years, attention has been directed towards identifying small molecule inhibitors of PHD. It is postulated that such inhibition might lead to a clinically useful strategy for protecting the myocardium against ischemia and reperfusion injury. Recently it has been reported that the orally absorbed PHD inhibitor GSK360A can modulate HIF-1α signaling and protect the failing heart following myocardial infarction. Furthermore, PHD1 deletion has been found to have beneficial effects through an increase in tolerance to hypoxia of skeletal muscle by reprogramming basal metabolism. In the mouse liver, such deletion has resulted in protection against ischemia and reperfusion. As a result of these preliminary findings, PHDs is attracting increasing interest as potential therapeutic targets in a wide range of diseases.
Authors:
Sucharita Senbanerjee; Mahesh Thirunavukkarasu; Muhammad Tipu Rishi; Juan A Sanchez; Nilanjana Maulik; Gautam Maulik
Related Documents :
2331763 - Effect of duration of ventricular fibrillation on defibrillation efficacy in humans.
22263123 - N-terminal pro-b-type natriuretic peptide is useful to predict cardiac complications fo...
19201573 - Three-dimensional echocardiographic assessment of acquired left ventricular to right at...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-3-16
Journal Detail:
Title:  Toxicology mechanisms and methods     Volume:  -     ISSN:  1537-6524     ISO Abbreviation:  -     Publication Date:  2012 Mar 
Date Detail:
Created Date:  2012-3-19     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101134521     Medline TA:  Toxicol Mech Methods     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Division of Gastroenterology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, 02115, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  A synthetic rainbow trout linkage map provides new insights into the salmonid whole genome duplicati...
Next Document:  Enhanced payload and photo-protection for pesticides using nanostructured lipid carriers with corn o...